OL

Orient Life

Description

Orient Life

Investor Profile

Orient Life has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Clinical Trials, Health Care.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Health Care
  • Pharmaceutical
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orient Life frequently co-invest with?

Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 1
Mass General Brigham
North America, Massachusetts, United States, Somerville
Co-Investments: 1
GF Securities
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
Fujifilm
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
HOPU Investment Management Company
Asia, Hebei, China, Xicheng
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 2
HC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by Orient Life?

Lyndra Therapeutics

Watertown, Massachusetts, United States

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series BFeb 11, 2019
Amount Raised: $60,900,000
SQZ Biotech

Watertown, Massachusetts, United States

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

BiotechnologyLife ScienceTherapeutics
Series CAug 8, 2018
Amount Raised: $72,000,000